Endophthalmitis following intravitreal anti-VEGF injections in ambulatory surgical centre facility: incidence, management and outcome

Br J Ophthalmol. 2013 Dec;97(12):1609-12. doi: 10.1136/bjophthalmol-2013-303222. Epub 2013 Sep 24.

Authors

Kopal Mithal¹, Annie Mathai, Avinash Pathengay, Subhadra Jalali, Nidhi Relhan, Swapna Reddy Motukupally, Savitri Sharma, Taraprasad Das

Affiliation

¹ Srimati Kanuri Santhamma Centre for Vitreo Retinal diseases, Kallam Anji Reddy campus, L V Prasad Eye Institute, , Hyderabad, Andhra Pradesh, India.

PMID: 24064940
DOI: 10.1136/bjophthalmol-2013-303222

No abstract available

Publication types

Letter

MeSH terms

Adult
Angiogenesis Inhibitors / administration & dosage
Angiogenesis Inhibitors / adverse effects*
Antibodies, Monoclonal, Humanized / administration & dosage
Antibodies, Monoclonal, Humanized / adverse effects*
Bevacizumab
Endophthalmitis / chemically induced*
Endophthalmitis / epidemiology
Endophthalmitis / therapy*
Female
Humans
Incidence
Intravitreal Injections
Male
Middle Aged
Retrospective Studies
Treatment Outcome
Vascular Endothelial Growth Factor A / antagonists & inhibitors*

Substances

Angiogenesis Inhibitors
Antibodies, Monoclonal, Humanized
VEGFA protein, human
Vascular Endothelial Growth Factor A
Bevacizumab